ID   RGPA1_HUMAN             Reviewed;        2036 AA.
AC   Q6GYQ0; A6NMA4; B9EK38; C5NU19; O94960; Q6GYP9; Q6ZT23; Q86YF3; Q86YF5;
AC   Q8ND69;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   28-JUN-2023, entry version 162.
DE   RecName: Full=Ral GTPase-activating protein subunit alpha-1;
DE   AltName: Full=GAP-related-interacting partner to E12;
DE            Short=GRIPE;
DE   AltName: Full=GTPase-activating Rap/Ran-GAP domain-like 1;
DE   AltName: Full=Tuberin-like protein 1;
DE   AltName: Full=p240;
GN   Name=RALGAPA1; Synonyms=GARNL1, KIAA0884, TULIP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RX   PubMed=15498464; DOI=10.1016/j.ygeno.2004.04.013;
RA   Schwarzbraun T., Vincent J.B., Schumacher A., Geschwind D.H., Oliveira J.,
RA   Windpassinger C., Ofner L., Ledinegg M.K., Kroisel P.M., Wagner K.,
RA   Petek E.;
RT   "Cloning, genomic structure and expression profile of TULIP1 (GARNL1), a
RT   brain-expressed candidate gene for 14q13-linked neurological phenotypes and
RT   its murine homolog.";
RL   Genomics 84:577-586(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6), VARIANT ALA-931, AND MUTAGENESIS OF
RP   ASN-1903.
RX   PubMed=19520869; DOI=10.1074/jbc.m109.012112;
RA   Shirakawa R., Fukai S., Kawato M., Higashi T., Kondo H., Ikeda T.,
RA   Nakayama E., Okawa K., Nureki O., Kimura T., Kita T., Horiuchi H.;
RT   "Tuberous sclerosis tumor suppressor complex-like complexes act as GTPase-
RT   activating proteins for Ral GTPases.";
RL   J. Biol. Chem. 284:21580-21588(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1147-2036 (ISOFORM 1), AND NUCLEOTIDE SEQUENCE [LARGE
RP   SCALE MRNA] OF 1719-2036 (ISOFORM 5).
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1167-2036 (ISOFORM 4).
RC   TISSUE=Lymph node;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1361-2036 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-778, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-773, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-797, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-754 AND SER-773, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-754; SER-860; SER-861 AND
RP   SER-864, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-711; SER-721; THR-754;
RP   SER-773; SER-797; SER-860 AND SER-861, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-986; SER-990 AND SER-994, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   INVOLVEMENT IN NEDHRIT, VARIANTS NEDHRIT 204-GLU--HIS-2036 DEL;
RP   376-ARG--HIS-2036 DEL; SER-1076 AND 1911-SER--HIS-2036 DEL, AND
RP   CHARACTERIZATION OF VARIANT NEDHRIT SER-1076.
RX   PubMed=32004447; DOI=10.1016/j.ajhg.2020.01.002;
RA   Wagner M., Skorobogatko Y., Pode-Shakked B., Powell C.M., Alhaddad B.,
RA   Seibt A., Barel O., Heimer G., Hoffmann C., Demmer L.A., Perilla-Young Y.,
RA   Remke M., Wieczorek D., Navaratnarajah T., Lichtner P., Klee D.,
RA   Shamseldin H.E., Al Mutairi F., Mayatepek E., Strom T., Meitinger T.,
RA   Alkuraya F.S., Anikster Y., Saltiel A.R., Distelmaier F.;
RT   "Bi-allelic variants in RALGAPA1 cause profound neurodevelopmental
RT   disability, muscular hypotonia, infantile spasms, and feeding
RT   abnormalities.";
RL   Am. J. Hum. Genet. 106:246-255(2020).
CC   -!- FUNCTION: Catalytic subunit of the heterodimeric RalGAP1 complex which
CC       acts as a GTPase activator for the Ras-like small GTPases RALA and
CC       RALB. {ECO:0000250}.
CC   -!- SUBUNIT: Component of the heterodimeric RalGAP1 complex with RALGAPB.
CC       Heterodimerization is required for activity. Interacts with the HLH
CC       region of TCF3/isoform E12 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC       Note=Translocated to the nucleus, when associated with TCF3/E12.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=Q6GYQ0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6GYQ0-2; Sequence=VSP_011328;
CC       Name=3;
CC         IsoId=Q6GYQ0-3; Sequence=VSP_011324, VSP_011325, VSP_011326;
CC       Name=4;
CC         IsoId=Q6GYQ0-4; Sequence=VSP_011327;
CC       Name=5;
CC         IsoId=Q6GYQ0-5; Sequence=VSP_011329;
CC       Name=6;
CC         IsoId=Q6GYQ0-6; Sequence=VSP_011324;
CC       Name=7;
CC         IsoId=Q6GYQ0-7; Sequence=VSP_054485;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:15498464}.
CC   -!- DISEASE: Neurodevelopmental disorder with hypotonia, neonatal
CC       respiratory insufficiency, and thermodysregulation (NEDHRIT)
CC       [MIM:618797]: An autosomal recessive disorder characterized by profound
CC       neurodevelopmental disability, muscular hypotonia, feeding
CC       abnormalities, recurrent fever episodes, infantile spasms, and moderate
CC       dysmorphic facial features. Brain imaging shows thin corpus or
CC       dysplastic corpus callosum, and additional unspecific abnormalities
CC       including gray matter heterotopias, ectopic posterior pituitary, signal
CC       abnormalities in basal ganglia, and stratum subependymale.
CC       {ECO:0000269|PubMed:32004447}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC86772.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY596970; AAT49271.1; -; mRNA.
DR   EMBL; AY596971; AAT49272.1; -; mRNA.
DR   EMBL; AB511280; BAH83561.1; -; mRNA.
DR   EMBL; AB020691; BAA74907.1; -; mRNA.
DR   EMBL; AL137818; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL160231; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL162311; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC042013; AAH42013.1; -; mRNA.
DR   EMBL; BC042045; AAH42045.1; -; mRNA.
DR   EMBL; BC150596; AAI50597.1; -; mRNA.
DR   EMBL; AL834362; CAD39026.1; -; mRNA.
DR   EMBL; AK126975; BAC86772.1; ALT_INIT; mRNA.
DR   CCDS; CCDS32064.1; -. [Q6GYQ0-2]
DR   CCDS; CCDS32065.1; -. [Q6GYQ0-1]
DR   CCDS; CCDS61439.1; -. [Q6GYQ0-7]
DR   CCDS; CCDS61440.1; -. [Q6GYQ0-6]
DR   RefSeq; NP_001269972.1; NM_001283043.2. [Q6GYQ0-7]
DR   RefSeq; NP_001269973.1; NM_001283044.2. [Q6GYQ0-6]
DR   RefSeq; NP_001317004.1; NM_001330075.2.
DR   RefSeq; NP_001333172.1; NM_001346243.1. [Q6GYQ0-1]
DR   RefSeq; NP_001333174.1; NM_001346245.1. [Q6GYQ0-6]
DR   RefSeq; NP_001333175.1; NM_001346246.1.
DR   RefSeq; NP_001333176.1; NM_001346247.1.
DR   RefSeq; NP_001333177.1; NM_001346248.1.
DR   RefSeq; NP_001333178.1; NM_001346249.1.
DR   RefSeq; NP_055805.1; NM_014990.2. [Q6GYQ0-1]
DR   RefSeq; NP_919277.2; NM_194301.3. [Q6GYQ0-2]
DR   AlphaFoldDB; Q6GYQ0; -.
DR   BioGRID; 128998; 70.
DR   IntAct; Q6GYQ0; 21.
DR   MINT; Q6GYQ0; -.
DR   STRING; 9606.ENSP00000302647; -.
DR   GlyCosmos; Q6GYQ0; 1 site, 1 glycan.
DR   GlyGen; Q6GYQ0; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q6GYQ0; -.
DR   PhosphoSitePlus; Q6GYQ0; -.
DR   BioMuta; RALGAPA1; -.
DR   DMDM; 51315850; -.
DR   EPD; Q6GYQ0; -.
DR   jPOST; Q6GYQ0; -.
DR   MassIVE; Q6GYQ0; -.
DR   MaxQB; Q6GYQ0; -.
DR   PaxDb; Q6GYQ0; -.
DR   PeptideAtlas; Q6GYQ0; -.
DR   ProteomicsDB; 66328; -. [Q6GYQ0-1]
DR   ProteomicsDB; 66329; -. [Q6GYQ0-2]
DR   ProteomicsDB; 66330; -. [Q6GYQ0-3]
DR   ProteomicsDB; 66331; -. [Q6GYQ0-4]
DR   ProteomicsDB; 66332; -. [Q6GYQ0-5]
DR   ProteomicsDB; 66333; -. [Q6GYQ0-6]
DR   ProteomicsDB; 7535; -.
DR   Antibodypedia; 79; 97 antibodies from 20 providers.
DR   DNASU; 253959; -.
DR   Ensembl; ENST00000307138.10; ENSP00000302647.6; ENSG00000174373.17. [Q6GYQ0-2]
DR   Ensembl; ENST00000382366.7; ENSP00000371803.3; ENSG00000174373.17. [Q6GYQ0-7]
DR   Ensembl; ENST00000389698.7; ENSP00000374348.3; ENSG00000174373.17. [Q6GYQ0-1]
DR   Ensembl; ENST00000553892.2; ENSP00000451877.1; ENSG00000174373.17. [Q6GYQ0-6]
DR   GeneID; 253959; -.
DR   KEGG; hsa:253959; -.
DR   UCSC; uc001wti.3; human. [Q6GYQ0-1]
DR   AGR; HGNC:17770; -.
DR   CTD; 253959; -.
DR   DisGeNET; 253959; -.
DR   GeneCards; RALGAPA1; -.
DR   HGNC; HGNC:17770; RALGAPA1.
DR   HPA; ENSG00000174373; Low tissue specificity.
DR   MalaCards; RALGAPA1; -.
DR   MIM; 608884; gene.
DR   MIM; 618797; phenotype.
DR   neXtProt; NX_Q6GYQ0; -.
DR   OpenTargets; ENSG00000174373; -.
DR   PharmGKB; PA165479278; -.
DR   VEuPathDB; HostDB:ENSG00000174373; -.
DR   eggNOG; KOG3686; Eukaryota.
DR   GeneTree; ENSGT00950000183139; -.
DR   HOGENOM; CLU_001676_0_0_1; -.
DR   InParanoid; Q6GYQ0; -.
DR   OMA; FLEVIYH; -.
DR   OrthoDB; 21929at2759; -.
DR   PhylomeDB; Q6GYQ0; -.
DR   TreeFam; TF324484; -.
DR   PathwayCommons; Q6GYQ0; -.
DR   Reactome; R-HSA-9013407; RHOH GTPase cycle.
DR   SignaLink; Q6GYQ0; -.
DR   SIGNOR; Q6GYQ0; -.
DR   BioGRID-ORCS; 253959; 39 hits in 1185 CRISPR screens.
DR   ChiTaRS; RALGAPA1; human.
DR   GeneWiki; GARNL1; -.
DR   GenomeRNAi; 253959; -.
DR   Pharos; Q6GYQ0; Tbio.
DR   PRO; PR:Q6GYQ0; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q6GYQ0; protein.
DR   Bgee; ENSG00000174373; Expressed in endothelial cell and 197 other tissues.
DR   ExpressionAtlas; Q6GYQ0; baseline and differential.
DR   Genevisible; Q6GYQ0; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0090630; P:activation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro.
DR   Gene3D; 3.40.50.11210; Rap/Ran-GAP; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR035974; Rap/Ran-GAP_sf.
DR   InterPro; IPR000331; Rap/Ran_GAP_dom.
DR   InterPro; IPR046859; RGPA/RALGAPB_N.
DR   InterPro; IPR027107; Tuberin/Ral-act_asu.
DR   PANTHER; PTHR10063:SF3; RAL GTPASE-ACTIVATING PROTEIN SUBUNIT ALPHA-1; 1.
DR   PANTHER; PTHR10063; TUBERIN; 1.
DR   Pfam; PF20412; RALGAPB_N; 1.
DR   Pfam; PF02145; Rap_GAP; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF111347; Rap/Ran-GAP; 1.
DR   PROSITE; PS50085; RAPGAP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Cytoplasm; Disease variant;
KW   GTPase activation; Nucleus; Phosphoprotein; Reference proteome.
FT   CHAIN           1..2036
FT                   /note="Ral GTPase-activating protein subunit alpha-1"
FT                   /id="PRO_0000056753"
FT   DOMAIN          1796..2004
FT                   /note="Rap-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00165"
FT   REGION          343..384
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          476..497
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          715..753
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          849..910
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          982..1009
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1327..2035
FT                   /note="Minimal domain that binds to TCF3/E12"
FT                   /evidence="ECO:0000250"
FT   COILED          1716..1744
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        348..363
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        364..384
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        715..747
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        894..910
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         711
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         721
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         754
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         773
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         778
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18220336"
FT   MOD_RES         797
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         860
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         861
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         864
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         986
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         990
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         994
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1000
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O55007"
FT   MOD_RES         1002
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GYP7"
FT   MOD_RES         1004
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O55007"
FT   MOD_RES         1478
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O55007"
FT   VAR_SEQ         755
FT                   /note="V -> VAMRSRSIGECALPSAYIRSAKSAPVLIHTSKPFLPDIVLTPLSDEL
FT                   S (in isoform 3 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10048485,
FT                   ECO:0000303|PubMed:19520869"
FT                   /id="VSP_011324"
FT   VAR_SEQ         812..825
FT                   /note="VNKEDMSQKLPPLN -> EAEQNATRGSTEGSVQSCNGLFWKESC (in
FT                   isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_054485"
FT   VAR_SEQ         1036..1057
FT                   /note="EISEFPSECCSVMAGGTLTGWH -> GNISKLDIYLFSFRASVSGDHK (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10048485"
FT                   /id="VSP_011325"
FT   VAR_SEQ         1058..2036
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10048485"
FT                   /id="VSP_011326"
FT   VAR_SEQ         1898..2036
FT                   /note="LRHLGNDEVHIVWSEHTRDYRRGIIPTEFGDVLIVIYPMKNHMFSIQIMKKP
FT                   EVPFFGPLFDGAIVNGKVLPIMVRATAINASRALKSLIPLYQNFYEERARYLQTIVQHH
FT                   LEPTTFEDFAAQVFSPAPYHHLPSDADH -> MESHCVAQAGVQWHDLRSLQLLPPRFK
FT                   ESSLLSLLSSWDYRCMPPHLSNFCIFSRDGVSPCWPG (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_011327"
FT   VAR_SEQ         2035..2036
FT                   /note="DH -> GSYPEILPSETPTATQVDGADLASPMSPRTSKSRMSMKLRRSSGSA
FT                   NKS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15498464"
FT                   /id="VSP_011328"
FT   VAR_SEQ         2035..2036
FT                   /note="DH -> VERNAVIVLFLPKPPLENIGHLKAPTQRFYPVKLPQQRR (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011329"
FT   VARIANT         204..2036
FT                   /note="Missing (in NEDHRIT)"
FT                   /evidence="ECO:0000269|PubMed:32004447"
FT                   /id="VAR_083728"
FT   VARIANT         376..2036
FT                   /note="Missing (in NEDHRIT)"
FT                   /evidence="ECO:0000269|PubMed:32004447"
FT                   /id="VAR_083729"
FT   VARIANT         931
FT                   /note="T -> A (in dbSNP:rs2274068)"
FT                   /evidence="ECO:0000269|PubMed:19520869"
FT                   /id="VAR_019804"
FT   VARIANT         1076
FT                   /note="N -> S (in NEDHRIT; undetectable protein expression;
FT                   dbSNP:rs1595085511)"
FT                   /evidence="ECO:0000269|PubMed:32004447"
FT                   /id="VAR_083730"
FT   VARIANT         1911..2036
FT                   /note="Missing (in NEDHRIT)"
FT                   /evidence="ECO:0000269|PubMed:32004447"
FT                   /id="VAR_083731"
FT   MUTAGEN         1903
FT                   /note="N->K: Has no effect on interaction with RALGAPB but
FT                   causes loss of activity."
FT                   /evidence="ECO:0000269|PubMed:19520869"
FT   CONFLICT        779
FT                   /note="G -> A (in Ref. 3; BAA74907)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1270
FT                   /note="K -> N (in Ref. 6; CAD39026)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2036 AA;  229832 MW;  7ADF5487908C14CB CRC64;
     MFSKKPHGDV KKSTQKVLDT KKDALTRLKH LRIVIENAES IDLKQFFDQH FSHIYYVFFE
     NFVTIEASLK QKGHKSQREE LDAILFIFEK ILQLLPERIH QRWQFHSIGL ILKKLLHTGN
     SLKIRREGVR LFLLWLQALQ NNCSKEQLWM FSCLIPGFSA PQSEHGPRTL DNLINPPLNL
     QETQVTIEEI TPLVPPQSGD KGQEDLTSYF LEALLKYIVI QVKSLEWKNK ENQERGFSFL
     FSHFKKYYLP YIFPNICKEN SLYHPILDIP QMRPKPHYVV IKKDAETNEA IYCTKEPFIK
     ARVIVIRWLV SFWLEPKPHT GPHIPGMEGE VLPKNIQRAA ASLVSREESK NDNADKTDRT
     TEPEQSHSNT STLTEREPSS SSLCSIDEEH LTDIEIVRRV FSSKRSNVNF VTEIFRQAFL
     LPICEAAAMR KVVKVYQEWI QQEEKPLFMQ EPEEIVITSS DLPCIENVTD HDISMEEGEK
     REEENGTNTA DHVRNSSWAK NGSYQGALHN ASEEATEQNI RAGTQAVLQV FIINSSNIFL
     LEPANEIKNL LDEHTDMCKR ILNIYRYMVV QVSMDKKTWE QMLLVLLRVT ESVLKMPSQA
     FLQFQGKKNM TLAGRLAGPL FQTLIVAWIK ANLNVYISRE LWDDLLSVLS SLTYWEELAT
     EWSLTMETLT KVLARNLYSL DLSDLPLDKL SEQKQKKHKG KGVGHEFQKV SVDKSFSRGW
     SRDQPGQAPM RQRSATTTGS PGTEKARSIV RQKTVDIDDA QILPRSTRVR HFSQSEETGN
     EVFGALNEEQ PLPRSSSTSD ILEPFTVERA KVNKEDMSQK LPPLNSDIGG SSANVPDLMD
     EFIAERLRSG NASTMTRRGS SPGSLEIPKD LPDILNKQNQ MRPIDDPGVP SEWTSPASAG
     SSDLISSDSH SDSFSAFQYD GRKFDNFGFG TDTGVTSSAD VDSGSGHHQS AEEQEVASLT
     TLHIDSETSS LNQQAFSAEV ATITGSESAS PVHSPLGSRS QTPSPSTLNI DHMEQKDLQL
     DEKLHHSVLQ TPDDLEISEF PSECCSVMAG GTLTGWHADV ATVMWRRMLG ILGDVNSIMD
     PEIHAQVFDY LCELWQNLAK IRDNLGISTD NLTSPSPPVL IPPLRILTPW LFKATMLTDK
     YKQGKLHAYK LICNTMKRRQ DVSPNRDFLT HFYNIMHCGL LHIDQDIVNT IIKHCSPQFF
     SLGLPGATML IMDFIVAAGR VASSAFLNAP RVEAQVLLGS LVCFPNLYCE LPSLHPNIPD
     VAVSQFTDVK ELIIKTVLSS ARDEPSGPAR CVALCSLGIW ICEELVHESH HPQIKEALNV
     ICVSLKFTNK TVAHVACNML HMLVHYVPRL QIYQPDSPLK IIQILIATIT HLLPSTEASS
     YEMDKRLVVS LLLCLLDWIM ALPLKTLLQP FHATGAESDK TEKSVLNCIY KVLHGCVYGA
     QCFSNPRYFP MSLSDLASVD YDPFMHLESL KEPEPLHSPD SERSSKLQPV TEVKTQMQHG
     LISIAARTVI THLVNHLGHY PMSGGPAMLT SQVCENHDNH YSESTELSPE LFESPNIQFF
     VLNNTTLVSC IQIRSEENMP GGGLSAGLAS ANSNVRIIVR DLSGKYSWDS AILYGPPPVS
     GLSEPTSFML SLSHQEKPEE PPTSNECLED ITVKDGLSLQ FKRFRETVPT WDTIRDEEDV
     LDELLQYLGV TSPECLQRTG ISLNIPAPQP VCISEKQEND VINAILKQHT EEKEFVEKHF
     NDLNMKAVEQ DEPIPQKPQS AFYYCRLLLS ILGMNSWDKR RSFHLLKKNE KLLRELRNLD
     SRQCRETHKI AVFYVAEGQE DKHSILTNTG GSQAYEDFVA GLGWEVNLTN HCGFMGGLQK
     NKSTGLTTPY FATSTVEVIF HVSTRMPSDS DDSLTKKLRH LGNDEVHIVW SEHTRDYRRG
     IIPTEFGDVL IVIYPMKNHM FSIQIMKKPE VPFFGPLFDG AIVNGKVLPI MVRATAINAS
     RALKSLIPLY QNFYEERARY LQTIVQHHLE PTTFEDFAAQ VFSPAPYHHL PSDADH
//
